Venrock has promoted Matt Trevithick to partner. He is based in the VC firm's Menlo Park, Calif. officer, and focuses on opportunities in the energy sector. www.venrock.com
Solera Holdings LLC, a San Ramon, Calif.-based claims processing company, priced 26.25 million common shares at $16 per share, for an IPO take of approximately $420 million. It had filed to sell around 21.88 million shares at between $15 and $17 per share. It will trade on the NYSE under ticker symbol SLH, while Goldman […]
Biodel Inc., a Danbury, Conn.-based drug improvement company focused on endocrine disorders like diabetes and osteoporosis, priced five million common shares at $15 per share ($14-$16 range), for an IPO take of approximately $75 million. It will trade on the Nasdaq under ticker symbol BIOD, while Morgan Stanley and Banc of America Securities served as […]
RSC Holdings Inc., a Scottsdale, Ariz.-based construction equipment rental company, has set its proposed IPO terms to around 20.83 million common shares being offered at between $23 and $25 per share. It plans to trade on the NYSE under ticker symbol RRR, with Morgan Stanley, Deutsche Bank and Lehman Brothers serving as co-lead underwriters. The […]
Interface21, a San Francisco-based provider of open-source software for building and deploying mission-critical enterprise applications, has raised $10 million in Series A funding from Benchmark Capital. Peter Fenton, a Benchmark general partner, will serve on the Interface21 board of directors. www.interface21.com
StrataGent Life Sciences Inc., a San Jose, Calif.-based developer of non-invasive versions of drugs that would otherwise be injected, has raised $16 million in Series B funding. Essex Woodlands Health Ventures led the deal, and was joined by Aphelion Capital and return backer Quantum Technology Partners.
ProCertus BioPharm Inc., a Madison, Wis.-based developer of therapeutics to protect cancer patients against the side effects of chemotherapy and radiotherapy, has raised $2.3 million in Series A funding. Venture Investors LLC was joined by seed backer Novartis Venture Fund. www.procertus.com
Penfund, a Toronto-based private equity fund focused on the middle-markets, has held a Cdn$240 million first close on its third fund. It expects to hold a final close on around Cdn$250 million within the next few weeks. www.penfund.com
Pegasus Biologics Inc., an Irvine, Calif.-based developer of bioimplants for soft-tissue repair and wound care for diabetic ulcers, has raised $20 million in Series C funding. Onset Ventures led the deal, and was joined Affinity Capital Management and return backers Three Arch Partners and Frazier Healthcare Ventures. The company previously had raised just under $12 […]
Draper Fisher Jurvetson and FIR Capital Partners have formed a joint $40 million venture capital fund focused on early-stage opportunities in Brazil. The two firms also will launch a $100 million Brazil fund later this year, which will target non-Brazilian limited partners. www.dfj.com www.firpartners.com